Invesco boosts share in Smith & Nephew | Wall Street Beat
November 7, 2012 by MassDevice staff
Invesco raises its stake in medical device company Smith & Nephew by more than 20%.
Invesco, a Atlanta-based investment management firm, bought up another clutch of Smith & Nephew (FTSE:SN, NYSE:SNN) shares, taking its total stake in the British medical device company to nearly 12%, according to regulatory filings.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
Navigation
NEWS
Healthcare reform will help lower the federal deficit, CBO says | MassDevice.com On Call
The Congressional Budget Office says that healthcare reform and other proposals in the White House's...
MassDevice.com +3 | The top 3 med-tech stories for May 20, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Biosensors International wins CE Mark for latest line of drug-eluting stents
Biosensors International lands European approval for its BioMatrix NeoFlex drug-eluting stent.
ViewRay closes in on $17.4M round
Medical device company ViewRay announces a $17.4 million funding round, offering equity and Series D-...
Diabetes: Abbott's glucose monitor software glitch gets FDA's highest-risk recall
The FDA slaps its highest-risk classification on Abbott Labs' FreeStyle InsuLinx blood glucose meter...
